Linperlisib (YY-20394) is a potent, orally bioavailable and selective inhibitor of PI3Kδ extracted from patent WO 2015055071 A1, compound 10; has an IC50 of 6.4 nM
产品描述:
Linperlisib (YY-20394) is a potent, orally bioavailable and selective inhibitor of PI3Kδ extracted from patent WO 2015055071 A1, compound 10; has an IC50 of 6.4 nM
靶点:
PI3Kδ:6.4 nM (IC50);PI3K
体外研究:
Linperlisib (YY-20394) is under the study for the recurrent and/or refractory follicular lymphoma.